editor | Webnewswire

Japan – Astellas, Eisai, Daiichi Sankyo and Takeda Agree to Collaborate to Reduce Environmental Burden in the Field of Pharmaceutical Packaging

Dec 22, 2022 | Business

Astellas Pharma Inc. (TSE: 4503), Eisai Co., Ltd. (TSE: 4523), Daiichi Sankyo Company, Limited (TSE: 4568) and Takeda Pharmaceutical Company Limited. (TSE: 4502/ NYSE:TAK) today announced that the four companies have agreed the collaboration to reduce environmental burden in the field of pharmaceutical packaging.

Based on the agreement, the four companies will aim to promote the use of more environmentaly friendly packaging for pharmaceutical products by sharing knowledge on packaging technologies to reduce environmental burden, such as blister packs made of biomass-based plastic instead of petroleum-derived plastic, compact packaging, recycled packaging materials, and recyclable packaging materials.

Astellas, Eisai, Daiichi Sankyo, and Takeda aim to ensure that society benefits from this collaboration to harmonize corporate activities with the global environment. In the future, the four companies expect to expand this collaboration beyond the four companies by calling on other companies in order to reduce further environmental burden.

Initiatives for Sustainability (Environment) of Each Company

Astellas has set “Deepen our engagement in sustainability” as one of the strategic goals in its Corporate Strategic Plan 2021. The reduction of environmental burden is one of Astellas’ priority themes within sustainability. For more information on specific initiatives, please visit our website.

Eisai established the “Eisai Environmental Management Vision” this fiscal year, and in addition to climate change countermeasures aimed at achieving carbon neutrality by fiscal 2040, Eisai has formed a medium- to long-term plan for environmental issues including efficient use of water and recycling of resources, and will work to further advance these efforts. To learn more about our environmental initiatives, please visit our website.

As a healthcare company with the Purpose “to contribute to the enrichment of quality of life around the world,” Daiichi Sankyo considers global environmental conservation, which is the basis of life and livelihood, as a key management issue (Materiality) and promotes environmental management. For more information on specific initiatives, please visit our website.

At Takeda, “Purpose-led Sustainability” is about creating both business and societal value through its core business. Takeda continues to reduce our operational carbon footprint and are now committed to achieving net-zero GHG emissions for scopes 1 and 2 before 2035 and for Scope 3 before 2040. For more information, see our Annual Integrated Report.

About Astellas

Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We are promoting the Focus Area Approach that is designed to identify opportunities for the continuous creation of new drugs to address diseases with high unmet medical needs by focusing on Biology and Modality. Furthermore, we are also looking beyond our foundational Rx focus to create Rx+ healthcare solutions that combine our expertise and knowledge with cutting-edge technology in different fields of external partners. Through these efforts, Astellas stands on the forefront of healthcare change to turn innovative science into value for patients. For more information, please visit our website at www.astellas.com/en.

About Eisai

Eisai’s Corporate Concept is “to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides.” Under this Concept [also known as our human health care (hhc) Concept], we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.

In addition, our continued commitment to the elimination of neglected tropical diseases (NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), is demonstrated by our work on various activities together with global partners.

For more information about Eisai, please visit www.eisai.com (for global headquarters: Eisai Co., Ltd.), and connect with us on Twitter @Eisai_SDGs

About Daiichi Sankyo

Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world- class science and technology for our purpose “to contribute to the enrichment of quality of life around the world.” In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies for people with cancer as well as other diseases with high unmet medical needs. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an “Innovative Global Healthcare Company Contributing to the Sustainable Development of Society.” For more information, please visit www.daiichisankyo.com.

About Takeda

Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions. For more information, visit www.takeda.com.

Contacts for inquiries or additional information:

Astellas Pharma Inc.
Corporate Advocacy & Relations
+81 3 3244 3201

Eisai Co., Ltd.
Public Relations Department
+81 3 3817 5120

Daiichi Sankyo Co., Ltd.
Corporate Communications Department
+81 3 6225 1126

Takeda Pharmaceutical Company Limited Global External Corporate Communications
+81 3 3278 2314

Sectors: BioTech

Rx Announces A Wholly Owned Subsidiary In Shenzhen

Dec 21, 2022 | Business

South China has always been an important market for RX. Back in 2007, RX founded a joint venture in Shenzhen, RX Huabo, which has continuously expanded its brand influence with Shenzhen Gift Show as its core event, which is also known as the name card of Shenzhen City. Today, RX Huabo organizes over 10 gifts and home events across different cities in China every year. Another joint venture of RX, Reed Sinopharm, has been organizing China International Medical Equipment Fair (CMEF), a world-class flagship event in medical and healthcare industry, in Shenzhen over years. Whats more, RX also organizes a series of exhibitions specific to electronics, touch screen and display, smart manufacturing in Shenzhen every year, including NEPCON ASIA, C-TOUCH & DISPLAY, FILM & TAPE EXPO, and S-FACTORY.

Shenzhen’s convention and exhibition industry started in 1999. After over 20 years of rapid development, Shenzhen has become one of the most famous cities for conventions and exhibitions in China. Statistics show that Shenzhen boasted a total of 5.03 million square meters area for exhibition in 2021, an increase of 27.34% over 2019. Shenzhen is accelerating its pace to become a top international exhibition city. Given by historical opportunities, such as the drive from the Guangdong-Hong Kong-Macau Greater Bay Area development program and the city’s status as a pilot zone of socialism with Chinese characteristics and various reforms since the start of Chinas 14th Five-Year Plan period, the city will develop 20 strategic emerging industry clusters focused on advanced manufacturing covering semiconductors and integrated circuits, UHD displays, intelligent terminals, intelligent connected vehicles, new materials, high-end medical equipment, healthcare, modern fashion, and etc. The city is working hard to create a technical and industrial innovation highland with global impact.

Therefore, RX decided to seize the immense opportunities brought by Shenzhen’s development strategies and policies, to make the best of the times, and to deeply cultivate its influence in the Greater Bay Area market. RX (Shenzhen) Exhibitions Co., Ltd. is thus born under these circumstances. Mr. Michael Cheng, President of RX Greater China, commented: “RX will further develop its business in China. We will fully combine our unrivaled industry resources and expertise in hosting online and offline events with the Greater Bay Area’s advantages in industry clusters, geographical location, and exhibition environment. We are working with partners to foster more international exhibitions with greater industry influence and a strong driving effect in Shenzhen, to promote business exchanges and economic prosperity of the Greater Bay Area. Looking forward, we are planning to launch more high-quality exhibitions in automobiles, packaging, and new materials industry, to help enterprises in the Greater Bay Area maintain and expand domestic and overseas business.”

The Commerce Bureau of Shenzhen Municipality welcomed the new subsidiary of RX, a world-renowned event organizer, and indicates that this move shows RXs confidence in the superior exhibition environment and promising prospects of Shenzhen convention and exhibition industrys high-quality development. The move is expected to contribute to Shenzhen’s efforts of building an international convention and exhibition city and building a highland of the convention and exhibition industry in the Greater Bay Area. The bureau hopes that RX could introduce more international brand exhibitions and conferences to Shenzhen in the future.

About RX (Reed Exhibitions)
RX is in the business of building businesses for individuals, communities, and organisations. We elevate the power of face-to-face events by combining data and digital products to help customers learn about markets, source products and complete transactions at over 400 events in 22 countries across 43 industry sectors. RX is passionate about making a positive impact on society and is fully committed to creating an inclusive work environment for all our people. RX is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.

About RXGC (Reed Exhibitions Greater China)
After four decades of rapid growth in China, RX has made its name as a well-respected and professional event organizer in Greater China. RXGC comprises multiple member companies and joint ventures. RXGC boasts about 500 employees, serving 12 industries with focus on 7 core sectors: Automotive Manufacturing; Electronics Manufacturing; Smart Manufacturing; Gifts & Retail; Medical & Healthcare; Printing & Packaging; Catering & Recreation. RXGC organizes about 70 events each year with over 2 million square meters of total show floor space, bringing together more than 30,000 exhibitors and 1 million visitors from China and abroad. In addition, RXGC stages 100+ online events throughout the year, providing business connections and transaction, insights sharing and knowledge learning for related communities.

###

Skin Grip Offers $25K in Diabetes Scholarships

Dec 21, 2022 | Business

Skin Grip, which makes adhesives for keeping diabetic sensors in place, is offering 25 $1,000 college scholarships to students with diabetes. Applications are due by February 1.

Skin Grip’s motto is “live fearlessly,” and the company helps diabetics do just that with their ultra-strong patches and tape that keep diabetic devices secured to the skin. The company is announcing its annual scholarship, which helps students persevere through the challenges of diabetes to earn college degrees.

Skin Grip’s scholarship funds 25 $1,000 awards for students with diabetes. Applicants must be high school seniors, undergraduate students in a two or four-year degree program, or graduate students. To apply, they must create a video of two minutes or less showing how they live fearlessly with diabetes.

“College is expensive as it is, and diabetes heaps on even more costs,” said Isaac Parkinson, Skin Grip founder. “There are doctor visits, insulin, and diabetic devices like continuous glucose monitors and insulin pumps. We want to help relieve the financial burdens on students with diabetes so they can thrive in college.”

Skin Grip got its start when Parkinson was inspired by his brother to create adhesive patches for the Dexcom G6 and other diabetic devices. His brother was diagnosed with diabetes at a young age and dealt with many day-to-day challenges, including having his diabetes sensors fall off of his skin and get lost or damaged. To date, Skin Grip has served 40,000 diabetic customers and prevented them from having to spend an estimated $15 million on replacement sensors.

“It’s hard to exercise and even sleep when you’re afraid you’re going to lose your continuous glucose monitor and have to spend a lot of money to replace it,” said Parkinson. His company’s proprietary patches and tape keep diabetic sensors in place whether the user is swimming, running, or sweating at the gym.

Scholarship winners from past years hail from all corners of the country and have unique stories about pushing beyond the limitations of diabetes. One high school senior from Texas studied graphic design and became the editor-in-chief of his high school yearbook while battling not only type 1 diabetes but also scoliosis and hyperthyroidism. A winner from Maine powered through her daily diabetes challenges to become the captain of her school’s soccer and speech teams and serve as the student body president. Yet another winner experienced homelessness as a child in Louisiana and is now using her Skin Grip scholarship to become the first college graduate in her family.

“We’re very proud of these Skin Grip scholarship winners who show that diabetes doesn’t need to keep you from living an active and full life,” said Parkinson.

Enrollment for the Skin Grip diabetes scholarship closes on February 1, 2023. Winners will be announced on March 1. The scholarship is just one of Skin Grip’s many initiatives to benefit the diabetic community. For example, on the 11th day of each month (commemorating January 11, 1922, when insulin was first used to treat diabetes), the company donates 100% of website profits to a diabetes-related charity of their customers’ choice.

To learn more about Skin Grip adhesives and their charitable giving, visit www.SkinGrip.com.

About Skin Grip

Skin Grip makes strong adhesive tapes to keep monitors secured to the skin so that diabetics can participate in their favorite activities with peace of mind. They offer patches for all types of glucose monitors and insulin pumps.

Cannes Lions 2022: Throwback from DecenterAds

Dec 21, 2022 | Business

The Cannes Lions International Festival of Creativity is an international event that gathers thousands of players from the global advertising and creative community. Amidst crazy competition — in 2022, there were over a quarter million entries to Cannes Lions — only the best of the best works get the cherished award. Thus the first reason to attend this and similar events is to get a grip on advertising best practices.

Being overloaded with digital advertising every moment on the Internet, users develop “banner blindness” and lower their attention threshold to cut out as much informational noise as possible. To break through and get the ads seen, advertisers should know what works — and that’s exactly what the winner cases tell. Both advertisers and publishers can benefit from learning what inventory, tactics, and messages to invest in for better results, and what’s best to leave behind.

The second reason to add Cannes Lions to the event’s schedule is the programmatic and ad-tech trends that the best industry experts like Dentsu, Google, and others share there. DecenterAds’ business development manager, attending the event in French Riviera on June 20-24, 2022, learned great insights on metaverse, Web3, and NFT — the advertising industry’s top overarching trends.

Last but not least, global events like Cannes Lions are invaluable sources of networking and new partnerships. All creative industry specialists need to reach their audiences to get results from their campaigns, and that’s where the importance of programmatic advertising can’t be overlooked. Creativity festivals give brands and agencies great opportunities to expand their inventories with the help of new partners like DecenterAds.

To learn more about DecenterAds’ advertising platform, visit decenterads.com.

DecenterAds
Albina Yefanova
+6591731742
https://decenterads.com
Address: 60 Paya Lebar Road, #04-51
Paya Lebar Square, Singapore 409051

Contact

ArKay Beverages and Walmart

Dec 21, 2022 | Business

Did you know that almost 50% of Drinkers want to reduce the consumption of alcohol and 52% of drinkers want to replace alcohol with non-alcoholic beverages?

What’s the reason for drinking less alcohol? People, especially Youth, want to improve their physical and mental health.

ArKay Beverages have the mission to replace alcoholic beverages with non-alcoholic wine, beer, and cocktails. They are providing alternatives on retail shelves, restaurants, and bars.

Now, the good thing is that Walmart is supporting ArKay Beverages to change the lives of millions of consumers in the USA. There are 15 million people in America who are alcoholics, and want to reduce their alcohol consumption from their daily life. That’s the reason Walmart is opening its doors and allows ArKay beverages to sell non-alcoholic products in America. Ignoring the pressure of the alcohol industry and introducing consumers of their brand to the ArKay brand is an industry win for both Walmart and the non-alcoholic brand ArKay.

Walmart is making a big step into the world of non-alcoholic alcohol. This is an exceptional turn in the trend of spirits and liquors. Walmart once again is the leader of a new trend in health, non-alcoholic spirits, and joining with ArKay Zero Proof. ArKay Beverages applaud Walmart for what they are doing in opening their doors to the ArKay product and creating this trend for Americans for a new healthy way to enjoy life.

According to ArKay Beverages, “Walmart is the first one to carry non-alcoholic spirits of this kind at this level. These are perfect for the holidays and the holiday season and to start the new year off with health and a healthy lifestyle in mind.”

For Walmart, ArKay Beverages would like to tell the entire world that this is the first time ever that ArKay alcohol-free spirits are available at Walmart. The fact that it is sold at Walmart allows millions of people that do not drink to stay sober. ArKay was created by Reynald Grattagliano in 2011; it contains the all-natural warm molecule that gives you the warm effect in your mouth as liquor does.

The alcohol-free spirits category is a $50 billion category. Walmart is now the leader of the category, as it is estimated that Walmart will represent 50% of the category.

ArKay Beverages say, “People enjoy the sipping and flavor of traditional alcohol and cocktails while alcohol-free beverages take us on a path of wellness and mental health that makes us happy, healthy, and refreshed in the morning.”

According to ArKay’s below are the some benefits of Non-Alcoholic drinks:

Help to Lose Weight: Are you trying to cut back on calories? Alcohol-free Beverages help you in this case. Consuming fewer calories and sugar helps you to lose weight in a healthy way.

Stay Hydrated: Standard alcohol is a diuretic, and it drains out all of the liquid from your body. It ultimately causes dehydration leading to exhaustion, headache, and unpleasant hangovers. Alcohol-free beverages do not cause dehydration, but it keeps you hydrated and fresh all day.

According to ArKay Beverages, “The healthy way to boost your mood in a delicious way is to drink Alcohol and gluten-free beverages. Drinking alcohol disrupts hormonal balance and causes depression. At the same time, alcohol-free beverages keep you balanced.”

A message from ArKay Beverages and Walmart:
“Do not let your fitness and health goals hold you to join the Christmas Party! Grab a healthy alternative (ArKay Alcohol-Free Beverage) and enjoy the Night.”

Japan – Astellas, Eisai, Daiichi Sankyo and Takeda Agree to Collaborate to Reduce Environmental Burden in the Field of Pharmaceutical Packaging

Rx Announces A Wholly Owned Subsidiary In Shenzhen

Skin Grip Offers $25K in Diabetes Scholarships

Cannes Lions 2022: Throwback from DecenterAds

ArKay Beverages and Walmart

Ads

Categories

Archives

Recent Posts